Login

Reflecting on My Failure to Make Gumroad a Billion Dollar Company|Sahil Lavingia,Founder,SHL Capital 00:10:00

Share On Facebook Share On Twitter

Founder and CEO of Gumroad. Previously, he was early at Pinterest.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
ALIGNED WITH MANAGEMENT TO BUILD VALUE|Jeff Dombek,Vice President,The Jordan Company, L.P.
00:10:00
Senco Gold & Diamonds CEO Suvankar Sen Shares Exclusive Insights with SVAR | Mr. Suvankar Sen, CEO, Senco Gold & Diamonds.
00:10:00
The Future of Medicine is Predictive|Stephanie Campbell,General Partner,The Artemis Fund
00:10:00
Insights on Asia's Economic Landscape with Mike from Henderson Far East Income Ltd
00:10:00
Grover Cleveland: The Inaccessible Man|Troy Senik
00:10:00
Rethinking Tradition: Roger Kruse on IRS Practices | Roger C. Kruse - principal and founding partner of FFP Wealth Management
00:10:00
Livingbridge Announces Strategic Partnership with Gresham House | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Charting the Course: Navigating Turbulent Waters in LNG and Shipping | Oystein Kalleklev - CEO of avance gas holding ltd
00:10:00
Joe Sachetta discusses insights and experiences from Sachetta & Callahan.
00:10:00
"Insights from Dave Mazza, Head of Research for SPDR ETFs and SSGA Funds at State Street Global Advisors: An Interview with Tom Lydon on VettaFi"
00:10:00
Expanding Horizons: The Case for Adding International Stocks to Your Portfolio
00:10:00
Power of Disrupting Financial Systems|Kwame Anku,Chairman & CEO,Black Star Fund

© 2017 - Neuhu+